Skip to main content
Premium Trial:

Request an Annual Quote

Biocrates: Nicolas Schauer, Moritz Seuster, Wulf Fischer-Knuppertz

Austria-based Biocrates announced that it has appointed Nicolas Schauer as co-CEO and CSO along with Moritz Seuster as co-CEO and CFO. Wulf Fischer-Knuppertz is resigning from the firm's executive board and will continue to serve as a consultant. Prior to joining Biocrates, Schauer sold his own metabolite profiling company in 2017. 

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.